Clik here to view.
22nd Century Technology is a “Game Changer”
Wednesday, August 23rd 2017 at 1:50pm UTC FDA plan to reduce nicotine in cigarettes to non-addictive levels “could save more lives than any other act of a governmental agency in all of human history.”...
View ArticleClik here to view.
Bristol-Myers Squibb and Pfizer Present Investigational Eliquis® (apixaban)...
Monday, August 28th 2017 at 9:00am UTC Data presented at ESC Congress 2017; highlighted in official hot line presentation and press program PRINCETON, N.J. & NEW YORK–(BUSINESS WIRE)–...
View ArticleClik here to view.
Hubble Contacts Closes Series A-III Financing to Support Global Growth
Monday, August 28th 2017 at 9:00am UTC Subscription Contact Lens Brand Sets Sights on Canada and Beyond Following a $10MM Raise NEW YORK–(BUSINESS WIRE)– Hubble, America’s first direct-to-consumer...
View ArticleClik here to view.
Agilent Technologies to Present at Morgan Stanley Global Healthcare Conference
Thursday, August 24th 2017 at 4:00pm UTC SANTA CLARA, Calif.–(BUSINESS WIRE)– Agilent Technologies Inc. (NYSE: A) today announced the following webcast for the investment community: Morgan Stanley...
View ArticleClik here to view.
Veracyte to Present at the Morgan Stanley 15th Annual Global Healthcare...
Thursday, August 24th 2017 at 2:00pm UTC SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)– Veracyte, Inc. (NASDAQ: VCYT) today announced that Bonnie H. Anderson, chairman and chief executive officer, will...
View ArticleClik here to view.
Glaukos Announces 2017 Investor Day and Webcast
Thursday, August 31st 2017 at 11:00am UTC SAN CLEMENTE, Calif.–(BUSINESS WIRE)– Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and...
View ArticleClik here to view.
Enanta Pharmaceuticals to Present at Three Upcoming Investor Conferences
Wednesday, August 30th 2017 at 8:00pm UTC WATERTOWN, Mass.–(BUSINESS WIRE)– Enanta Pharmaceuticals, Inc., (NASDAQ:ENTA), a research and development-focused biotechnology company dedicated to creating...
View ArticleClik here to view.
Amyloid Publishes Long-Term Data Analysis from Pfizer Suggesting Tafamidis...
Thursday, August 31st 2017 at 12:54pm UTC Analysis Provides Longest Evaluation of Any Medication for Hereditary Transthyretin Amyloid Polyneuropathy (TTR-FAP), a Neurodegenerative Disease NEW...
View ArticleClik here to view.
Bristol-Myers Squibb and Pfizer Alliance Announce Real-World Observational...
Tuesday, August 29th 2017 at 12:21pm UTC Eliquis® (apixaban) associated with lower risk of stroke and lower rates of major bleeding compared to warfarin in U.S. Humana database analysis PRINCETON,...
View ArticleClik here to view.
Cerus to Present at Two Upcoming Conferences
Wednesday, August 30th 2017 at 12:30pm UTC CONCORD, Calif.–(BUSINESS WIRE)– Cerus Corporation (NASDAQ:CERS) announced today that William ‘Obi’ Greenman, Cerus’ president and chief executive officer,...
View ArticleClik here to view.
CEL-SCI to Present at the 19th Annual Rodman & Renshaw Global Investment...
Wednesday, August 30th 2017 at 12:00pm UTC VIENNA, Va.–(BUSINESS WIRE)– CEL-SCI Corporation (NYSE American: CVM), today announced Geert Kersten, Chief Executive Officer, will be presenting at the 19th...
View ArticleClik here to view.
Immune Pharmaceuticals Provides R&D and Business Update and Summary of Recent...
Monday, August 28th 2017 at 12:00pm UTC NEW YORK–(BUSINESS WIRE)– Immune Pharmaceuticals Inc. (NASDAQ:IMNP) (“Immune” or the “Company”) provided the following R&D and business update and summary...
View ArticleClik here to view.
OncLive® Presents State of the Science Summit™: Treatment Options in Ovarian...
Tuesday, August 29th 2017 at 2:07pm UTC Thought leaders to provide in-depth insight on emerging treatments and research CRANBURY, N.J.–(BUSINESS WIRE)– OncLive®, a leading digital provider of...
View ArticleClik here to view.
FOTIVDA®▼ (tivozanib) est dorénavant autorisé dans l’Union européenne pour le...
Tuesday, August 29th 2017 at 9:06am UTC HEMEL HEMPSTEAD, Angleterre–(BUSINESS WIRE)– EUSA Pharma (EUSA) a annoncé aujourd’hui que la Commission européenne (CE) a homologué FOTIVDA® pour la gestion des...
View ArticleClik here to view.
PerkinElmer to Present at Morgan Stanley Global Healthcare Conference
Monday, August 28th 2017 at 8:15pm UTC WALTHAM, Mass.–(BUSINESS WIRE)– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company...
View ArticleClik here to view.
Synlogic to Webcast Presentation at BioCentury’s 24th Annual NewsMakers in...
Friday, September 1st 2017 at 12:30pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Synlogic (Nasdaq:SYBX) announced today that its chief medical officer, Aoife Brennan, M.B., B.Ch., will present a company...
View ArticleClik here to view.
Arrowhead Pharmaceuticals to Host R&D Day on RNAi-Based Therapies
Friday, September 1st 2017 at 11:30am UTC PASADENA, Calif.–(BUSINESS WIRE)– Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it will host a Research & Development Day to discuss...
View ArticleClik here to view.
Ligand to Participate in Two Upcoming Investor Conferences
Friday, September 1st 2017 at 1:00pm UTC SAN DIEGO–(BUSINESS WIRE)– Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces that company executives are scheduled to participate in the following...
View ArticleClik here to view.
Pfizer Receives FDA Approval for MYLOTARG™ (gemtuzumab ozogamicin)
Friday, September 1st 2017 at 3:38pm UTC Only approved antibody-drug conjugate for newly diagnosed and relapsed or refractory CD33-positive acute myeloid leukemia Reintroduction of MYLOTARG supported...
View ArticleClik here to view.
Taro Announces Joining of CEO
Friday, September 1st 2017 at 8:05pm UTC HAWTHORNE, N.Y.–(BUSINESS WIRE)– Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) announced today that Mr. Uday Baldota has joined the...
View Article